<p>AIM ImmunoTech Inc. has entered into a Note Purchase Agreement with Streeterville Capital, LLC, resulting in the sale of an unsecured promissory note with an original principal amount of $3,301,250. The agreement, finalized on November 18, 2025, includes an original issuance discount of $781,250 and an additional $20,000 paid by AIM ImmunoTech to cover the investor’s transaction costs, bringing the net proceeds to $2,500,000. The note carries a 10% annual interest rate compounded daily and matures 24 months from issuance. AIM ImmunoTech is required to make mandatory prepayments from future fundraising, and the note includes customary default provisions, with the interest rate increasing to 22% per annum in the event of default. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. AIM ImmunoTech Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001493152-25-024156), on November 19, 2025, and is solely responsible for the information contained therein. © Copyright 2025 - Public Technologies (PUBT) Original Document: here</p>

<p>AIM ImmunoTech Inc. secured a $3.3 million unsecured loan from Streeterville Capital, with net proceeds of $2.5 million after discounts and transaction costs. The loan has a 10% annual interest rate, maturing in 24 months, with mandatory prepayments from future fundraising. Default provisions increase the interest rate to 22%.</p>

AIM ImmunoTech Secures $3.3 Million Unsecured Loan from Streeterville Capital